Trial record 2 of 3 for:    GM602

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) (GALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01854294
Recruitment Status : Completed
First Posted : May 15, 2013
Last Update Posted : August 8, 2017
Columbia University
Massachusetts General Hospital
Information provided by (Responsible Party):
Genervon Biopharmaceuticals, LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : July 2014
  Certification/Extension First Submitted : August 1, 2017